Data Indicate Prostate Cancer Screening Saves Lives. Medscape (4/24, Johnson) reports, “For the first time, updated results from the European Randomized Study of Screening for Prostate Cancer (ERSPC), the largest randomized prostate cancer screening trial in the world, show a significant survival advantage with prostate-specific antigen (PSA) screening for men from 50 to 74 years of…
read more